Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes

Alexander Spratt, Lauren S. Blieden, Sander R. Dubovy, Audina Berrocal, Richard K. Lee

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Purpose: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. Patients and Methods: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. Results: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. Conclusions: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.

Original languageEnglish (US)
Pages (from-to)e160-e162
JournalJournal of glaucoma
Issue number4
StatePublished - 2017


  • VEGF
  • bevacizumab
  • membrane
  • neovascular
  • pupillary

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes'. Together they form a unique fingerprint.

Cite this